Chemomab Therapeutics Ltd ADR (CMMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,906 | 7,564 | 7,123 | 5,596 | 8,478 |
| Marketable Securities | 2,137 | 2,802 | 3,082 | 3,917 | 2,225 |
| Receivables | 3,431 | 3,059 | N/A | 1,101 | 1,274 |
| TOTAL | $11,474 | $13,425 | $11,926 | $10,614 | $11,977 |
| Non-Current Assets | |||||
| PPE Net | 167 | 176 | 188 | 217 | 237 |
| Other Non-Current Assets | 167 | 211 | 254 | 298 | 605 |
| TOTAL | $334 | $387 | $442 | $515 | $842 |
| Total Assets | $11,808 | $13,812 | $12,368 | $11,129 | $12,819 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 204 | 485 | 194 | 378 | 490 |
| Accrued Expenses | 296 | 337 | 464 | 666 | 1,644 |
| Other current liabilities | 613 | 656 | 479 | 386 | N/A |
| TOTAL | $1,113 | $1,478 | $1,137 | $1,430 | $2,247 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 179 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $179 |
| Total Liabilities | $1,113 | $1,478 | $1,137 | $1,430 | $2,426 |
| Shareholders' Equity | |||||
| Retained earnings | -113,391 | -111,618 | -109,745 | -108,003 | -105,946 |
| TOTAL | $10,695 | $12,334 | $11,231 | $9,699 | $10,393 |
| Total Liabilities And Equity | $11,808 | $13,812 | $12,368 | $11,129 | $12,819 |